Cresemba (isavuconazonium sulfate) - Astellas, Basilea
Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failure. (PubMed, Ann Intensive Care) - May 30, 2026 - "ACLF did not significantly alter isavuconazole clearance during RRT. However, high PK variability and frequent subtherapeutic exposures support routine therapeutic drug monitoring in critically ill patients." 
Journal • PK/PD data • Critical care • Hepatology • Infectious Disease • Liver Failure
http://www.ncbi.nlm.nih.gov/pubmed/42212005
 
Christina König; Dominik Jarczak; Emily Behrens; Jens Martens-Lobenhoffer; Jörn Grensemann; Sebastian G Wicha; Stefan Kluge; Stefanie M Bode-Böger; Valentin Fuhrmann
 
May 30, 2026
 
Prev Next